Items where Author is "<span class="person_name">Jackson, M. J.</span>"
Number of items: 13.
Article
  • Continuous rotigotine administration reduces dyskinesia resulting from pulsatile treatment with rotigotine or L-DOPA in MPTP-treated common marmosets. (2010) K. A. Stockwell, D. K. A. Scheller, L. A. Smith, S. Rose, Mahmoud M. Iravani, M. J. Jackson and P. Jenner
  • Continuous administration of rotigotine to MPTP-treated common marmosets enhances anti-parkinsonian activity and reduces dyskinesia induction. (2009) K. A. Stockwell, D. Scheller, S. Rose, M. J. Jackson, K. Tayarani-Binazir, Mahmoud M. Iravani, L. A. Smith, C. W. Olanow and P. Jenner
  • Continuous delivery of ropinirole reverses motor deficits without dyskinesia induction in MPTP-treated common marmosets. (2008) K. A. Stockwell, D. J. Virley, M. Perren, Mahmoud M. Iravani, M. J. Jackson, S. Rose and P. Jenner
  • MPTP treatment of common marmosets impairs proteasomal enzyme activity and decreases expression of structural and regulatory elements of the 26S proteasome. (2006) Bai-Yun Zeng, Mahmoud M. Iravani, S. T. Lin, M. Irifune, M. Kuoppamaki, G. Al-Barghouthy, L. Smith, M. J. Jackson, S. Rose, A.D. Medhurst and P. Jenner
  • Unilateral pallidotomy in 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine-treated common marmosets exhibiting levodopa-induced dyskinesia. (2005) Mahmoud M. Iravani, S. Costa, G. Al-Bargouthy, M. J. Jackson, Bai-Yun Zeng, M. Kuoppamaki, J. A. Obeso and P. Jenner
  • A modified MPTP treatment regime produces reproducible partial nigrostriatal lesions in common marmosets. (2005) Mahmoud M. Iravani, E. Syed, M. J. Jackson, L. C. Johnston, L. A. Smith and P. Jenner
  • 3,4-methylenedioxymethamphetamine (ecstasy) inhibits dyskinesia expression and normalizes motor activity in 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine-treated primates. (2003) Mahmoud M. Iravani, M. J. Jackson, M. Kuoppamaki, L. A. Smith and P. Jenner
  • Behavioural and immunohistochemical changes following supranigral administration of sonic hedgehog in 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine-treated common marmosets. (2002) B. Dass, Mahmoud M. Iravani, M. J. Jackson, T. M. Engber, A. Galdes and P. Jenner
  • GDNF reverses priming for dyskinesia in MPTP-treated, L-DOPA-primed common marmosets. (2001) Mahmoud M. Iravani, S. Costa, M. J. Jackson, Banu C. Tel, C. Cannizzaro, R. K. B. Pearce and P. Jenner
  • Other
  • Continuous vs pulsatile administration of rotigotine in rat and monkey models of Parkinson's disease: A comparison. (2008) D. K. A. Scheller, W. J. Schmidt, M. J. Jackson, U. Ruess, K. Stockwell, M. Heindl, Mahmoud M. Iravani, K. Tayarani-Binazir, S. Rose and P. Jenner
  • The effects of pallidotomy on motor function in MPTP-treated, L-DOPA primed common marmosets. (2004) S. S. Costa, Mahmoud M. Iravani, M. J. Jackson and P. Jenner
  • Ecstasy (3,4-Methylenedioxymethamphetamine) inhibits dyskinesia expression and normalises locomotor activity in parkinsonian primates. (2002) Mahmoud M. Iravani, M. J. Jackson, G. Al-Barghouthy, M. Kouppamaki and P. Jenner
  • The effect of unilateral pallidotomy on motor disability, and L-dopa-induced dyskinesia in parkinsonian marmosets. (2002) Mahmoud M. Iravani, S. Costa, M. J. Jackson, G. Al-Bargouthy and P. Jenner